Neogen Corp (NEOG) is a publicly traded Healthcare sector company. As of May 21, 2026, NEOG trades at $8.83 with a market cap of $1.86B and a P/E ratio of -3.07. NEOG moved +5.75% today. Year to date, NEOG is +21.63%; over the trailing twelve months it is +42.42%. Its 52-week range spans $3.87 to $17.18. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces NEOG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Neogen Q3 Revenue Falls 4.4% to $211.2M; Food Safety Up 2.6%: Neogen’s third-quarter revenue fell 4.4% year-on-year to $211.2 million, driven by a 20.1% drop in Animal Safety sales while Food Safety revenue climbed 2.6% to $156.7 million. Adjusted EBITDA held at $48.2 million with a 22.8% margin as gross margin declined 300 basis points to 46.9% on manufacturing transition costs.
| Metric | Value |
|---|---|
| Price | $8.83 |
| Market Cap | $1.86B |
| P/E Ratio | -3.07 |
| EPS | $-2.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.18 |
| 52-Week Low | $3.87 |
| Volume | 3 |
| Avg Volume | 0 |
| Revenue (TTM) | $870.54M |
| Net Income | $-608.84M |
| Gross Margin | 45.20% |
2 analysts cover NEOG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.